Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Open accessThe DOI matches its Crossref record; 198 of the 206 references it cites were found in a registry or an index; 31 of the 258 sources its claims cite were checked for support.
Abstract
Steroid biosynthesis and metabolism are reflected by the serum steroid metabolome and, in even more detail, by the 24-hour urine steroid metabolome, which can provide unique insights into alterations of steroid flow and output indicative of underlying conditions. Mass spectrometry–based steroid metabolome profiling has allowed for the identification of unique multisteroid signatures associated with disorders of steroid biosynthesis and metabolism that can be used for personalized approaches to diagnosis, differential diagnosis, and prognostic prediction. Additionally, steroid metabolome analysis has been used successfully as a discovery tool, for the identification of novel steroidogenic disorders and pathways as well as revealing insights into the pathophysiology of adrenal disease. Increased availability and technological advances in mass spectrometry–based methodologies have refocused attention on steroid metabolome profiling and facilitated the development of high-throughput steroid profiling methods soon to reach clinical practice. Furthermore, steroid metabolomics, the combination of mass spectrometry–based steroid analysis with machine learning–based approaches, has facilitated the development of powerful customized diagnostic approaches. In this review, we provide a comprehensive up-to-date overview of the utility of steroid metabolome analysis for the diagnosis and management of inborn disorders of steroidogenesis and autonomous adrenal steroid excess in the context of adrenal tumors.
Overview
CoChat Summary
TL;DR
This review describes how serum and 24-hour urine steroid metabolome profiling, especially mass spectrometry–based multisteroid analysis, reveals distinct signatures of inborn steroid biosynthesis/metabolism disorders and autonomous adrenal steroid excess. It highlights steroid metabolomics—mass spectrometry plus machine learning—as a diagnostic, discovery, and prognostic tool, with an ACC malignant steroid fingerprint awaiting prospective validation.
Key findings
- The 24-hour urine steroid metabolome measures net steroid output and can reveal underlying enzymatic deficiencies and autonomous adrenal steroid excess; urinary excretion accounts for ∼80% of steroid excretion.
- Inborn errors show characteristic multisteroid signatures: >90% of congenital adrenal hyperplasia cases are caused by CYP21A2 deficiency, and diagnostic ratios can distinguish disorders, e.g., 5PT/PTONE is typically low (<1.5) in CYP21A2 deficiency but high (>35) in HSD3B2 deficiency.
- In adrenal tumors, routine serum biochemistry detects steroid excess in 60% to 70% of adrenocortical carcinoma (ACC) patients, whereas urine GC-MS profiling demonstrates steroid excess in >90%; a machine learning–derived “malignant steroid fingerprint” can differentiate ACC from adrenocortical adenoma with high sensitivity and specificity.
- Primary aldosteronism affects at least 5% of the hypertensive population, and many patients also cosecrete glucocorticoid and 11-oxygenated androgen metabolites (“Connshing syndrome”); adrenal masses are estimated in 5% of the general population, with only 5% of those being cortisol-producing adenomas manifesting as adrenal Cushing syndrome.
Methods
- Narrative review of published literature; no primary data or new patient cohort are presented.
- Synthesizes mass spectrometry–based steroid profiling approaches, including GC-MS for comprehensive urine steroid metabolite profiling and UHPLC-MS/MS for serum/plasma steroids and, more recently, urine steroid metabolites.
- Focuses on steroid metabolomics—combining mass spectrometry–based steroid analysis with machine learning–based data analysis—for diagnosis, differential diagnosis, and prognostic prediction in inborn steroidogenic disorders and autonomous adrenal steroid excess.
Limitations
- The paper states no formal limitations.
- Evident from the text: as a review, it provides no new primary data, and some cited evidence is retrospective or preliminary; the large-scale prospective validation study of the ACC urine steroid metabolomics test has been completed but results are awaited.
- Evident from the text: there is a paucity of published urine steroid profiling data in HSD17B3 deficiency, and no distinct steroid metabolome signature has been identified for other primary aldosteronism–causing mutations, mostly due to rarity of cases.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
23 Valid · 11 Not valid · 120 Not checked · 59 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The combination of mass spectrometry–based steroid profiling with machine learning–based data analysis has created a powerful discovery tool, steroid metabolomics, highly suited as a diagnostic biomarker approach (1–4).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Abstract
What the sources say
- Supportedcites [1] Arlt, 2011, Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors, J Clin Endocrinol Metab source
The Objective describes mass spectrometry-based steroid profiling followed by machine learning analysis as a steroid metabolomic approach. The Discussion calls the combination a highly promising biomarker approach for differentiating adrenal tumors, while noting that prospective validation is needed before routine clinical use. (LLM, conf=0.91)
- Not checked yetcites [2] Biehl M , SchneiderP, SmithDJ, StiekemaH, TaylorAE, HughesBA, ShackletonCHL, StewartPM, ArltW. Matrix relevance LVQ in steroid metabolomics based classification of adrenal tumors. Available at: www.i6doc.com/en/livre/?GCOI=28001100967420. Accessed 30 April 2019.
- Not checked yetcites [3] Bunte, 2018, Learning pharmacokinetic models for in vivo glucocorticoid activation, J Theor Biol source
- Not checked yetcites [4] Thomson, 2019, Simultaneous parameter estimation and variable selection via the logit-normal continuous analogue of the spike-and-slab prior, J R Soc Interface source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“P450 oxidoreductase (POR) is the crucial electron donor for microsomal cytochrome P450 (CYP) enzymes, including the steroidogenic enzymes CYP21A2, CYP17A1, and, to a lesser degree, CYP19A1 (11, 12).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > The steroid metabolome in congenital adrenal hyperplasia
What the sources say
- Supportedcites [11] Baranowski, 2018, Monogenic disorders of adrenal steroidogenesis, Horm Res Paediatr source
The “POR Deficiency” passage in the section “Monogenic Disorders Affecting Co-Factor Enzymes of Steroidogenesis” states the claim directly, including the lesser role of CYP19A1. The supplied passage does not specify a page. (LLM, conf=0.95)
- Partly supportedcites [12] Miller, 2011, The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders, Endocr Rev sourceExperimental — accuracy not yet measured
The “P450 oxidoreductase” section identifies POR as the sole electron-transfer protein for all microsomal P450s, including P450c21, P450c17, and P450aro. It does not establish that POR donates electrons to P450aro (CYP19A1) to a lesser degree; the “P450 oxidoreductase deficiency” section instead describes mutation-specific effects on P450aro activity. Page numbers are unavailable in our copy. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In contrast to 17,20-lyase deficiency in the context of CYP17A1 deficiency (see “CAH due to CYP21A2 deficiency” above), which always comes with a degree of impairment of CYP17A1 17α-hydroxylase activity, CYB5A deficiency represents “true” isolated 17,20-lyase deficiency (15, 70);”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of androgen biosynthesis and metabolism
What the sources say
- Supportedcites [15] Idkowiak, 2012, A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency, J Clin Endocrinol Metab source
The Discussion (page not specified) reports preserved 17α-hydroxylase activity with 17,20-lyase deficiency in the CYB5A-affected family. It contrasts this with previously reported CYP17A1-associated cases, in which 17α-hydroxylase activity was also impaired. (LLM, conf=0.91)
- Not checked yetcites [70] Kok, 2010, Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X, J Clin Endocrinol Metab source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, several previous studies did not find clinically significant androgen deficiency in affected patients (74–78).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of sulfation and desulfation
What the sources say
- Not checked yetcites [74] Sánchez-Guijo, 2016, Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: evidence from steroid sulfatase deficiency, Mol Cell Endocrinol source
- Not checked yetcites [75] Delfino, 1998, X-linked ichthyosis: relation between cholesterol sulphate, dehydroepiandrosterone sulphate and patient’s age, Br J Dermatol source
- Not checked yetcites [76] Lykkesfeldt, 1985, Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis, Clin Endocrinol (Oxf) source
- Partly supportedcites [77] Idkowiak, 2016, Steroid sulfatase deficiency and androgen activation before and after puberty, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The paper states in its introductory discussion that severe androgen deficiency had not been reported in STS deficiency. However, its Discussion says earlier studies provided little detailed clinical information, and one prior cohort found mild biochemical androgen deficiency. It therefore supports the absence of reported severe deficiency, but not the stronger implication that several studies assessed and found no clinically significant deficiency. (LLM, conf=0.81)
- Not checked yetcites [78] Ruokonen, 1986, Regulation of serum testosterone in men with steroid sulfatase deficiency: response to human chorionic gonadotropin, J Steroid Biochem source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“CRD is caused by HSD11B1 deficiency (90) whereas ACRD results form a deficiency in the activity of H6PDH, which is essential for maintaining the reductive activity of HSD11B1 in vivo by the reduced form of NAD phosphate provision to the enzyme (91, 92).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of cortisol activation and inactivation
What the sources say
- Not checked yetcites [91] Draper, 2003, Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency, Nat Genet source
- Supportedcites [92] Lavery, 2008, Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency, J Clin Endocrinol Metab source
The paper’s conclusions report that inactivating H6PD mutations cause cortisone reductase deficiency and prevent 11β-HSD1 from functioning as an oxoreductase. Its introductory passage explains that H6PDH supplies the NADPH required for 11β-HSD1 reductase activity in vivo, matching the mechanism attributed to this source. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
88 more claims · 7 with their cited sources checked
Create a free account to see all 213 claims and to verify the 227 references still open.
- It may state two separate claims as one. 109
- Probably not a substantial claim. 22
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with NC CAH, 11-oxo-androgens are elevated about 2-fold compared to women with clinical features of androgen excess, although 11-oxo-androgens alone cannot be used to establish the diagnosis of NC CAH (131).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [131]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies of the steroid profile of patients with congenital adrenal hyperplasia due to deficiencies of 17α-, 11β- or 21-hydroxylase (and POR), corroborate this physiological data, reinforcing the concept of a “MC (or non-17-hydroxylated) pathway of ZF ” ( 3 , 7 - 9 , 18 ).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, in 17OHD serum levels of B reach values 100 times higher than normal, in the range of 15 to 50 mcg/dL (normal: 0.1 to 0.6 mcg/dL).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although its GC activity is 10 times lower than cortisol, its abundant concentration provides enough GC activity to prevent “addisonian” manifestations in the affected patient ( 3 , 7 , 8 , 20 ).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“(i) DOC secretion is amplified by exogenous ACTH stimulation and easily blocked by dexamethasone administration”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of androgen biosynthesis and metabolism
“In contrast to 17,20-lyase deficiency in the context of CYP17A1 deficiency (see “CAH due to CYP21A2 deficiency” above)”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > The steroid metabolome in congenital adrenal hyperplasia
“#### CAH due to CYP17A1 deficiency”
Citations
Cites
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationScholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Steroid 5α-reductase 2 deficiency
Mendonca, B. B., Batista, R. L., Domenice, S., Costa, E. M. F., Arnhold, I. J. P., Russell, D. W., & Wilson, J. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.020 · Cited by 546
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationULICK, S., KODAMA, T., GUNCZIER, P., ZANCONATO, G., RAMIREZ, L. C., RAUH, W., ROSLER, A., BRADLOW, H. L., & NEW, M. I. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-5-757 · Cited by 496
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Self-citationConstitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310359 · Cited by 443
Krone, N., Hughes, B. A., Lavery, G. G., Stewart, P. M., Arlt, W., & Shackleton, C. H. L. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.04.010 · Cited by 434
Self-citationWilliams, R. T. (1959) · Chapman & Hall eBooks · Cited by 433
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citationMolecular genetics of steroid 5 alpha-reductase 2 deficiency
Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato-McGinley, J., Griffin, J. E., Francke, U., Wilson, J. D., & Russell, D. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115954 · Cited by 422
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
Self-citationDi Dalmazi, G., Vicennati, V., Garelli, S., Casadio, E., Rinaldi, E., Giampalma, E., Mosconi, C., Golfieri, R., Paccapelo, A., Pagotto, U., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70211-0 · Cited by 415
ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Assié, G., Libé, R., Espiard, S., Rizk-Rabin, M., Guimier, A., Luscap, W., Barreau, O., Lefèvre, L., Sibony, M., Guignat, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304603 · Cited by 395
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Scholl, U. I., Stölting, G., Nelson-Williams, C., Vichot, A. A., Choi, M., Loring, E., Prasad, M. L., Goh, G., Carling, T., Juhlin, C. C., et al. (2015) · eLife · doi:10.7554/elife.06315 · Cited by 358
Rossi, G. P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M. V., Bisogni, V., Mantero, F., & Pessina, A. C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01316 · Cited by 356
Steroid 5α-Reductase 2 Deficiency*
WILSON, J. D., GRIFFIN, J. E., & RUSSELL, D. W. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-577 · Cited by 346
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationTakagi, K., & Usuku, G. (1969) · PubMed · Cited by 328
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296
Self-citationLicorice-Induced Hypermineralocorticoidism
Farese, R. V., Biglieri, E. G., Shackleton, C. H. L., Irony, I., & Gomez-Fontes, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251706 · Cited by 295
Self-citationDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationSteroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Self-citationObservational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276
Self-citationA Survey on Adrenal Incidentaloma in Italy1
Mantero, F., Terzolo, M., Arnaldi, G., Osella, G., Masini, A. M., Alı̀, A., Giovagnetti, M., Opocher, G., & Angeli, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6372 · Cited by 272
Pascoe, L., Curnow, K. M., Slutsker, L., Connell, J. M., Speiser, P. W., New, M. I., & White, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8327 · Cited by 271
Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas
Debono, M., Bradburn, M., Bull, M., Harrison, B., Ross, R. J., & Newell-Price, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3007 · Cited by 269
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Scholl, U. I., Stölting, G., Schewe, J., Thiel, A., Tan, H., Nelson-Williams, C., Vichot, A. A., Jin, S. C., Loring, E., Untiet, V., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0048-5 · Cited by 266
Elhassan, Y. S., Alahdab, F., Prete, A., Delivanis, D. A., Khanna, A., Prokop, L., Murad, M. H., O'Reilly, M. W., Arlt, W., & Bancos, I. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3630 · Cited by 263
Self-citationBorn-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247
Self-citationTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Dinnes, J., Bancos, I., Ferrante di Ruffano, L., Chortis, V., Davenport, C., Bayliss, S., Sahdev, A., Guest, P., Fassnacht, M., Deeks, J. J., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0461 · Cited by 219
Self-citationConley, B. E. (1960) · JAMA · doi:10.1001/jama.1960.03020340081035 · Cited by 216
Maimoun, L., Philibert, P., Cammas, B., Audran, F., Bouchard, P., Fenichel, P., Cartigny, M., Pienkowski, C., Polak, M., Skordis, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1024 · Cited by 216
Boehmer, A. L. M., Brinkmann, A. O., Sandkuijl, L. A., Halley, D. J. J., Niermeijer, M. F., Andersson, S., de Jong, F. H., Kayserili, H., de Vroede, M. A., Otten, B. J., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6174 · Cited by 197
Williams, M. L., & Elias, P. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110391 · Cited by 193
Kamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191
Rich, G. M., Ulick, S., Cook, S., Wang, J. Z., Lifton, R. P., & Dluhy, R. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-10-813 · Cited by 186
Stewart, P. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3617 · Cited by 176
Self-citationInactivating PAPSS2 Mutations in a Patient with Premature Pubarche
Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C. G. J., Grinten, H. L. C.-V. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810489 · Cited by 169
Self-citationSomatic ATP1A1 , ATP2B3 , and KCNJ5 Mutations in Aldosterone-Producing Adenomas
Williams, T. A., Monticone, S., Schack, V. R., Stindl, J., Burrello, J., Buffolo, F., Annaratone, L., Castellano, I., Beuschlein, F., Reincke, M., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01733 · Cited by 167
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Self-citationWong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Self-citationPremature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
Self-citationEisenhofer, G., Dekkers, T., Peitzsch, M., Dietz, A. S., Bidlingmaier, M., Treitl, M., Williams, T. A., Bornstein, S. R., Haase, M., Rump, L. C., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.251199 · Cited by 158
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2851 · Cited by 154
Self-citationHomma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153
Congenital Methemoglobinemia with a Deficiency of Cytochrome B5
Hegesh, E., Hegesh, J., & Kaftory, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141206 · Cited by 150
Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Self-citationMONDER, C., SHACKLETON, C. H. L., BRADLOW, H. L., NEW, M. I., STONER, E., IOHAN, F., & LAKSHMI, V. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-550 · Cited by 145
Self-citationAldosterone synthase deficiency and related disorders
White, P. C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.013 · Cited by 140
Pubertal Presentation of Congenital Δ5–-3β–Hydroxysteroid Dehydrogenase Deficiency*
ROSENFIELD, R. L., RICH, B. H., WOLFSDORF, J. I., CASSORLA, F., PARKS, J. S., BONGIOVANNI, A. M., WU, C. H., & SHACKLETON, C. H. L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-345 · Cited by 135
Self-citationMorelli, V., Eller-Vainicher, C., Salcuni, A. S., Coletti, F., Iorio, L., Muscogiuri, G., Della Casa, S., Arosio, M., Ambrosi, B., Beck-Peccoz, P., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.398 · Cited by 135
Ulick, S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.963 · Cited by 135
Role of KCNJ5 in familial and sporadic primary aldosteronism
Mulatero, P., Monticone, S., Rainey, W. E., Veglio, F., & Williams, T. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.230 · Cited by 133
Phenotypic variability in 17β‐hydroxysteroid dehydrogenase‐3 deficiency and diagnostic pitfalls
Lee, Y. S., Kirk, J. M. W., Stanhope, R. G., Johnston, D. I., Harland, S., Auchus, R. J., Andersson, S., & Hughes, I. A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02829.x · Cited by 125
Epstein, E. H., Krauss, R. M., & Shackleton, C. H. L. (1981) · Science · doi:10.1126/science.6945674 · Cited by 124
Self-citationSubclinical hypercortisolism: a state, a syndrome, or a disease?
Di Dalmazi, G., Pasquali, R., Beuschlein, F., & Reincke, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0272 · Cited by 123
Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects.
Epstein, M. T., Espiner, E. A., Donald, R. A., & Hughes, H. (1977) · BMJ · doi:10.1136/bmj.1.6059.488 · Cited by 120
Caulfield, M. P., Lynn, T., Gottschalk, M. E., Jones, K. L., Taylor, N. F., Malunowicz, E. M., Shackleton, C. H. L., Reitz, R. E., & Fisher, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8712 · Cited by 120
Self-citationFukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
AN ABNORMALITY IN STEROID REDUCTIVE METABOLISM IN A HYPERTENSIVE SYNDROME
Ulick, S., Ramirez, L. C., & New, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-4-799 · Cited by 112
Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
Gerards, J., Heinrich, D. A., Adolf, C., Meisinger, C., Rathmann, W., Sturm, L., Nirschl, N., Bidlingmaier, M., Beuschlein, F., Thorand, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00299 · Cited by 112
Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma
Taylor, D. R., Ghataore, L., Couchman, L., Vincent, R. P., Whitelaw, B., Lewis, D., Diaz-Cano, S., Galata, G., Schulte, K.-M., Aylwin, S., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277624 · Cited by 109
Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years
Wu, V.-C., Chueh, S.-C. J., Chen, L., Chang, C.-H., Hu, Y.-H., Lin, Y.-H., Wu, K.-D., & Yang, W.-S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 107
Psychological Assessment of Primary Aldosteronism: A Controlled Study
Sonino, N., Tomba, E., Genesia, M. L., Bertello, C., Mulatero, P., Veglio, F., Fava, G. A., & Fallo, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2723 · Cited by 106
LYKKESFELDT, G., BENNETT, P., LYKKESFELDT, A. E., MICIC, S., MØLLER, S., & SVENSTRUP, B. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01096.x · Cited by 105
SHACKLETON, C. H. L., RODRIGUEZ, J., ARTEAGA, E., LOPEZ, J. M., & WINTER, J. S. D. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00160.x · Cited by 104
Self-citationIdkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Shackleton, C., Marcos, J., Arlt, W., & Hauffa, B. P. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30171 · Cited by 104
Self-citationDiagnostic value of urinary steroid profiling in the evaluation of adrenal tumors
Kerkhofs, T. M. A., Kerstens, M. N., Kema, I. P., Willems, T. P., & Haak, H. R. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0224-3 · Cited by 102
Keber, R., Motaln, H., Wagner, K. D., Debeljak, N., Rassoulzadegan, M., Ačimovič, J., Rozman, D., & Horvat, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253245 · Cited by 102
Bone involvement in aldosteronism
Salcuni, A. S., Palmieri, S., Carnevale, V., Morelli, V., Battista, C., Guarnieri, V., Guglielmi, G., Desina, G., Eller-Vainicher, C., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1660 · Cited by 101
Mechanisms of Type I and Type II Pseudohypoaldosteronism
Furgeson, S. B., & Linas, S. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050457 · Cited by 100
Ulick, S., & Chu, M. D. (1982) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968209061640 · Cited by 98
Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome
Eisenhofer, G., Masjkur, J., Peitzsch, M., Di Dalmazi, G., Bidlingmaier, M., Grüber, M., Fazel, J., Osswald, A., Beuschlein, F., & Reincke, M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.282582 · Cited by 96
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia
Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Miller Wolf, L., & Jabs, E. W. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10510 · Cited by 95
Lavery, G. G., Walker, E. A., Tiganescu, A., Ride, J. P., Shackleton, C. H. L., Tomlinson, J. W., Connell, J. M. C., Ray, D. W., Biason-Lauber, A., Malunowicz, E. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0743 · Cited by 95
Self-citationX-linked ichthyosis: An oculocutaneous genodermatosis
Fernandes, N. F., Janniger, C. K., & Schwartz, R. A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.04.028 · Cited by 95
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Biochemical diagnosis of Antley–Bixler syndrome by steroid analysis
Shackleton, C., Marcos, J., Malunowicz, E. M., Szarras‐Czapnik, M., Jira, P., Taylor, N. F., Murphy, N., Crushell, E., Gottschalk, M., Hauffa, B., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30104 · Cited by 86
Self-citationPlasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Schweitzer, S., Kunz, M., Kurlbaum, M., Vey, J., Kendl, S., Deutschbein, T., Hahner, S., Fassnacht, M., Dandekar, T., & Kroiss, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0782 · Cited by 85
Litchfield, W. R., New, M. I., Coolidge, C., Lifton, R. P., & Dluhy, R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4381 · Cited by 84
Apparent cortisone reductase deficiency: a unique form of hypercortisolism
Phillipov, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3855 · Cited by 83
Self-citationOostdijk, W., Idkowiak, J., Mueller, J. W., House, P. J., Taylor, A. E., O'Reilly, M. W., Hughes, B. A., de Vries, M. C., Kant, S. G., Santen, G. W. E., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3556 · Cited by 81
Self-citationSereg, M., Szappanos, Á., Tőke, J., Karlinger, K., Feldman, K., Kaszper, É., Varga, I., Gláz, E., Rácz, K., & Tóth, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0707 · Cited by 81
Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study
Wu, V.-C., Chang, C.-H., Wang, C.-Y., Lin, Y.-H., Kao, T.-W., Lin, P.-C., Chu, T.-S., Chang, Y.-S., Chen, L., Wu, K.-D., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3033 · Cited by 81
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy
Adolf, C., Köhler, A., Franke, A., Lang, K., Riester, A., Löw, A., Heinrich, D. A., Bidlingmaier, M., Treitl, M., Ladurner, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00617 · Cited by 81
Self-citationMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Self-citationNakamura, Y., Satoh, F., Morimoto, R., Kudo, M., Takase, K., Gomez-Sanchez, C. E., Honma, S., Okuyama, M., Yamashita, K., Rainey, W. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2785 · Cited by 78
Apparent mineralocorticoid excess: Type I and type II
Mantero, F., Palermo, M., Petrelli, M. D., Tedde, R., Stewart, P. M., & Shackleton, C. H. L. (1996) · Steroids · doi:10.1016/0039-128x(96)00012-8 · Cited by 77
Self-citationTomalik-Scharte, D., Maiter, D., Kirchheiner, J., Ivison, H. E., Fuhr, U., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0764 · Cited by 77
Shackleton, C., Pozo, O. J., & Marcos, J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00135 · Cited by 75
Self-citationJones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N., Hughes, B. A., O’Neil, D. M., Whitaker, M. J., Tomlinson, J. W., Storbeck, K.-H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2855 · Cited by 74
Self-citationThe biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone.
Ulick, S., Wang, J. Z., & Morton, D. H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592889 · Cited by 73
Ribes, V., Otto, D. M. E., Dickmann, L., Schmidt, K., Schuhbaur, B., Henderson, C., Blomhoff, R., Wolf, C. R., Tickle, C., & Dollé, P. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.10.032 · Cited by 73
Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., et al. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665480 · Cited by 73
Sánchez-Guijo, A., Oji, V., Hartmann, M. F., Traupe, H., & Wudy, S. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.d061499 · Cited by 73
Tiosano, D., Knopf, C., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 71
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.016 · Cited by 71
Practical approach to steroid 5alpha-reductase type 2 deficiency
Cheon, C. K. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1189-4 · Cited by 69
Can, S., Zhu, Y.-S., Cai, L.-Q., Ling, Q., Katz, M. D., Akgun, S., Shackleton, C. H. L., & Imperato-McGinley, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4535 · Cited by 69
Self-citationPrenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency
Reisch, N., Idkowiak, J., Hughes, B. A., Ivison, H. E., Abdul-Rahman, O. A., Hendon, L. G., Olney, A. H., Nielsen, S., Harrison, R., Blair, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3449 · Cited by 67
Self-citationSHACKLETON, C. H. L., HONOUR, J. W., DILLON, M. J., CHANTLER, C., & JONES, R. W. A. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-786 · Cited by 66
Self-citationRiepe, F. G. (2013) · Endocrine development · doi:10.1159/000342508 · Cited by 66
Velikanova, L. I., Shafigullina, Z. R., Lisitsin, A. A., Vorokhobina, N. V., Grigoryan, K., Kukhianidze, E. A., Strelnikova, E. G., Krivokhizhina, N. S., Krasnov, L. M., Fedorov, E. A., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0267-0 · Cited by 62
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014934108 · Cited by 61
Self-citationDillon, M. J., Leonard, J. V., Buckler, J. M., Ogilvie, D., Lillystone, D., Honour, J. W., & Shackleton, C. H. (1980) · Archives of Disease in Childhood · doi:10.1136/adc.55.6.427 · Cited by 61
Self-citationPAPSS2 mutations cause autosomal recessive brachyolmia
Miyake, N., Elcioglu, N. H., Iida, A., Isguven, P., Dai, J., Murakami, N., Takamura, K., Cho, T.-J., Kim, O.-H., Hasegawa, T., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101039 · Cited by 58
Lenders, J. W. M., Williams, T. A., Reincke, M., & Gomez-Sanchez, C. E. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0563 · Cited by 56
Taylor, N. F., & Shackleton, C. H. L. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-1-78 · Cited by 54
Self-citationAtanasov, A. G., Ignatova, I. D., Nashev, L. G., Dick, B., Ferrari, P., Frey, F. J., & Odermatt, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006111235 · Cited by 52
Lavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0628 · Cited by 50
Self-citationSerum 18-Hydroxycortisol in Primary Aldosteronism, Hypertension, and Normotensives
Mosso, L., Gómez-Sánchez, C. E., Foecking, M. F., & Fardella, C. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.688 · Cited by 50
Diagnosis of 5α-Reductase 2 Deficiency: Is Measurement of Dihydrotestosterone Essential?
Chan, A. O. K., But, B. W. M., Lee, C. Y., Lam, Y. Y., Ng, K. L., Tung, J. Y., Kwan, E., Chan, Y. K., Tsui, T. K. C., Lam, A., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196501 · Cited by 49
Sánchez‐Guijo, A., Neunzig, J., Gerber, A., Oji, V., Hartmann, M. F., Schuppe, H.-C., Traupe, H., Bernhardt, R., & Wudy, S. A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.019 · Cited by 49
Storbeck, K.-H., Gilligan, L., Jenkinson, C., Baranowski, E. S., Quanson, J. L., Arlt, W., & Taylor, A. E. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.03.033 · Cited by 49
Self-citation17α-Hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family
D'Armiento, M., Reda, G., Kater, C., Shackleton, C. H. L., & Biglieri, E. G. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-4-697 · Cited by 47
Self-citationLitchfield, W. R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3570 · Cited by 47
Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production
Hattangady, N. G., Karashima, S., Yuan, L., Ponce‐Balbuena, D., Jalife, J., Gómez-Sánchez, C. E., Auchus, R. J., Rainey, W. E., & Else, T. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0324 · Cited by 42
Steroid sulfatase deficiency and androgen activation before and after puberty
Idkowiak, J., Taylor, A. E., Subtil, S., O'Neil, D. M., Vijzelaar, R., Dias, R. P., Amin, R., Barrett, T. G., Shackleton, C. H. L., Kirk, J. M. W., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4101 · Cited by 42
Self-citationCM, J., A, M., N, R., N, N., N, K., BA, H., DM, O., MJ, W., JW, T., KH, S., et al. (2018) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.15.15.5 · Cited by 41
Self-citationPitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency
Khattab, A., Yuen, T., Yau, M., Domenice, S., Costa, E. M. F., Kazmi, D., Muhuri, D., Pina, C. E., Nishi, M. Y., Yang, A., et al. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0295 · Cited by 40
PETERSON, R. E., IMPERATO‐McGINLEY, J., GAUTIER, T., & SHACKLETON, C. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00181.x · Cited by 39
Self-citationMueller, J. W., Idkowiak, J., Gesteira, T. F., Vallet, C., Hardman-Kavanaugh, R. E., van den Boom, J., Dhir, V., Knauer, S. K., Rosta, E., & Arlt, W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002248 · Cited by 39
Self-citationIida, A., Simsek-Kiper, P. Ö., Mizumoto, S., Hoshino, T., Elcioglu, N., Horemuzova, E., Geiberger, S., Yesil, G., Kayserili, H., Utine, G. E., et al. (2013) · Human Mutation · doi:10.1002/humu.22377 · Cited by 37
Mutations in CYP11B1 gene: Phenotype–genotype correlations
Zhu, Y., Cordero, J. J., Can, S., Cai, L., You, X., Herrera, C., DeFillo‐Ricart, M., Shackleton, C., & Imperato‐McGinley, J. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20108 · Cited by 37
Self-citationJoannou, G. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90239-9 · Cited by 36
Kamrath, C., Hartmann, M. F., Boettcher, C., Zimmer, K.-P., & Wudy, S. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.013 · Cited by 34
Ghayee, H. K., Rege, J., Watumull, L. M., Nwariaku, F. E., Carrick, K. S., Rainey, W. E., Miller, W. L., & Auchus, R. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1222 · Cited by 34
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Self-citationMetabolism of Radiolabeled Corticosterone in an Adult with the 17α-Hydroxylase Deficiency Syndrome*
SHACKLETON, C. H. L., BIGLIERI, E. G., ROITMAN, E., & HONOUR, J. W. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-976 · Cited by 33
Self-citationKATER, C. E., BIGLIERI, E. G., ROST, C. R., SCHAMBELAN, M., HIRAI, J., CHANG, B. C. F., & BRUST, N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-225 · Cited by 32
Fukami, M., Nagai, T., Mochizuki, H., Muroya, K., Yamada, G., Takitani, K., & Ogata, T. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.023 · Cited by 30
Nguyen, H.-H., Hannemann, F., Hartmann, M. F., Małunowicz, E., Wudy, S. A., & Bernhardt, R. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.04.016 · Cited by 30
Marcos, J., Craig, W. Y., Palomaki, G. E., Kloza, E. M., Haddow, J. E., Roberson, M., Bradley, L. A., & Shackleton, C. H. L. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2284 · Cited by 30
Self-citationMatrix relevance LVQ in steroid metabolomics based classification of adrenal tumors
Biehl, M. L., Schneider, P., Smith, D. J., Stiekema, H., TAYLOR, A. E. R., Hughes, B. A., Shackleton, C. H. L., Stewart, P. M., & Arlt, W. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 30
Self-citationPozo, O. J., Marcos, J., Khymenets, O., Pranata, A., Fitzgerald, C. C., McLeod, M. D., & Shackleton, C. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0286 · Cited by 30
Self-citationHauffa, B. P., Sólyom, J., Gláz, E., Shackleton, C. H. L., Wambach, G. K., Vecsei, P., Stolecke, H., & Homoki, J. (1991) · European Journal of Pediatrics · doi:10.1007/bf01963554 · Cited by 28
Self-citationAbnormalities of aldosterone synthesis and action in children
White, P. C. (1997) · Current Opinion in Pediatrics · doi:10.1097/00008480-199708000-00019 · Cited by 28
Shackleton, C. H. L., & Reid, S. J. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.9.1906 · Cited by 28
Self-citationMultisteroid analysis in children with terminal aldosterone biosynthesis defects
Peter, M., Partsch, C., & Sippell, W. G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745009 · Cited by 27
Honour, J. W., Anderson, J. M., & Shackleton, C. H. L. (1983) · Acta Endocrinologica · doi:10.1530/acta.0.1030101 · Cited by 27
Self-citationGenetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry
Shackleton, C. H. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_26 · Cited by 26
Self-citationSpondyloepimetaphyseal dysplasia Pakistani type: Expansion of the phenotype
Tüysüz, B., Yılmaz, S., Gül, E., Kolb, L., Bilguvar, K., Evliyaoğlu, O., & Günel, M. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35906 · Cited by 25
Kraan, G. P. B., Wolthers, B. G., van der Molen, J. C., Nagel, G. T., Drayer, N. M., & Joannou, G. E. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90011-k · Cited by 24
Biochemical Diagnosis and Management of Corticosterone Methyl Oxidase Type II Deficiency
Lee, P., PATTERSON, B. D., Hintz, R. L., & Rosenfeld, R. G. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-225 · Cited by 24
Hána, V., Ježková, J., Kršek, M., Kršek, M., Hána, V., & Hill, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01926 · Cited by 24
Shackleton, C. H. L., Honour, J. W., Dillon, M. J., & Milla, P. J. (1976) · European Journal of Endocrinology · doi:10.1530/acta.0.0810762 · Cited by 23
Self-citationAldosterone synthase deficiency caused by a homozygous L451F mutation in the CYP11B2 gene
Nguyen, H.-H., Hannemann, F., Hartmann, M. F., Wudy, S. A., & Bernhardt, R. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.009 · Cited by 23
Honour, J. W., Dillon, M. J., & Shackleton, C. H. L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-325 · Cited by 23
Self-citationApparent mineralocorticoid excess syndromes
Shimojo, M., & Stewart, P. M. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349763 · Cited by 23
Beuschlein, F., Reincke, M., & Arlt, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001550 · Cited by 23
Self-citationChristakoudi, S., Cowan, D., Christakudis, G., & Taylor, N. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.07.013 · Cited by 22
The cortisol-cortisone shuttle and hypertension
Stewart, P. M., & Edwards, C. R. W. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90269-b · Cited by 21
Małnowicz, E. M., Mitkowska, Z., Bal, K., Niżankowska-Błaż, T., Moszczyńska, E., Iwanicka, Z., & Romer, T. E. (1997) · Hormone Research · doi:10.1159/000185529 · Cited by 20
Learning pharmacokinetic models for in vivo glucocorticoid activation
Bunte, K., Smith, D. J., Chappell, M. J., Hassan-Smith, Z. K., Tomlinson, J., Arlt, W., & Tiňo, P. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.07.025 · Cited by 19
Self-citationAkın, L., Kurtoğlu, S., Kendırcı, M., Akın, M. A., Hartmann, M. F., & Wudy, S. A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000281404 · Cited by 16
Reeder, A. Y., & Joannou, G. E. (1996) · Steroids · doi:10.1016/0039-128x(95)00193-t · Cited by 16
Thomson, W., Jabbari, S., TAYLOR, A. E. R., Arlt, W., & Smith, D. J. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2018.0572 · Cited by 16
Self-citationComparative Genomics and Transcriptome Profiling in Primary Aldosteronism
Prada, E. T. A., Castellano, I., Sušnik, E., Yang, Y., Meyer, L. S., Tetti, M., Beuschlein, F., Reincke, M., & Williams, T. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041124 · Cited by 15
Corticosterone methyl oxidase type II (CMO II) deficiency: Biochemical approach to diagnosis
Yong, A. B. W., Montalto, J., Pitt, J. J., Oakes, S., Preston, T., & Buchanan, C. R. (1994) · Clinical Biochemistry · doi:10.1016/0009-9120(94)00048-z · Cited by 13
Pitfalls in the Diagnosis of 5α-Reductase Type 2 Deficiency during Early Infancy
Perry, R., Novikova, E., Wallace, A. M., & Donaldson, M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324646 · Cited by 12
Ruoklonen, A., Oikarinen, A., & Vihko, R. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90289-x · Cited by 12
The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone
Ulick, S., Wang, J. Z., & Morton, D. H. (1993) · Pediatric Nephrology · doi:10.1007/bf00853213 · Cited by 11
Applying mass spectrometric methods to study androgen biosynthesis and metabolism in prostate cancer
Knuuttila, M., Hämäläinen, E. K., & POUTANEN, M. H. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0150 · Cited by 11
Neres, M. S., Auchus, R. J., Shackleton, C. H. L., & Kater, C. E. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000900009 · Cited by 10
Self-citationDelfino, M., Procaccini, Illiano, & Milone (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02180.x · Cited by 10
Glucocorticoid-remediable aldosteronism
Litchfield, W. R., & Dluhy, R. G. (1996) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199606000-00012 · Cited by 6
Glucocorticoid-remediable aldosteronism
Lifton, R. P., & Dluhy, R. G. (1994) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199400010-00022 · Cited by 5
Urinary steroid profile of a newborn suffering from pseudohypoaldosteronism
Wolthers, B. G., Kraan, G. P. B., van der Molen, J. C., Nagel, G. T., Rouwé, C. W., Lenting, F., & Boersma, E. R. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06034-7 · Cited by 4
Fennessey, P. V., Marsh, P. G., Orr, E. R., Burnstein, P., & Betz, G. (1983) · Clinica Chimica Acta · doi:10.1016/0009-8981(83)90145-6 · Cited by 3
Cited by
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 884
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“This has been extensively reviewed by Storbeck et al. (344).”
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
The Biosynthesis of Enzymatically Oxidized Lipids
Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 180
Metadata
- Authors
- Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., & Shackleton, C. H. L.
- Affiliations
- Stellenbosch University (ZA)
- University of Birmingham (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of California, San Francisco (US)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-07-11
- Volume
- 40
- Issue
- 6
- Pages
- 1605-1625
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6858476
- OpenAlex
- W2960176468
- Semantic Scholar
- 807dd6287c13d38cf71f318250f2bb11b80bb36b
- Cited by
- 141
- References
- 206
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 21 · 2023: 25 · 2022: 26 · 2021: 13 · 2020: 14 · 2019: 3
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (WT209492/Z/17/Z, WT101671AIA)
- Medical Research Council (G1001964, MR/R017913/1)
- Diabetes UK (18/0005782)
- Academy of Medical Sciences UK (NAF004\1002)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- steroid metabolome, adrenal steroidogenesis, serum steroids, adrenal tumors, personalized diagnosis, differential diagnosis, outcome prediction, machine learning
- MeSH terms
- Adrenal Gland Diseases, Diagnosis, Differential, Humans, Steroid Metabolism, Inborn Errors, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.